< Key Hightlight >

MARKET OUTLOOK 

As per Triton Market Research’s report, the North America non-PVC IV bags market is anticipated to grow with a CAGR of 6.77% during the forecast years from 2021 to 2028. The United States and Canada together form the market in this region.

The use of phthalates in coating the PVC material, which is used for producing IV bags, was observed to be harmful to human health. It was seen that exposure to phthalates was leading to neurodevelopmental issues in infants, also affecting their reproductive tract development. 

In 2006, the National Toxicology Program (NTP) put forth that exposure to phthalates such as DEHP affects the development of the reproductive tract among male infants less than a year old. Such health hazards have resulted in a restriction on the usage of PVC material for manufacturing medical products. Also, there is a growing focus on parenteral nutrition these days, which is raising the demand for better alternatives.

The restrictions on the usage of polyvinyl chloride for manufacturing medical products are believed to facilitate the speedy adoption of non-PVC alternatives. This has consequently enhanced the adoption of non-PVC IV bags as well. This, in turn, is expected to boost the growth of the studied market in Canada in the coming years.

COMPETITIVE OUTLOOK

The dominant players in the non-PVC IV bags market are B Braun Melsungen AG, Baxter International Inc, Sealed Air, Huaren Pharmaceutical, Medipharmaplan, JW Life Science, ICU Medical, and Shanghai Xin Gen Eco Technologies.